Very preterm birth generally refers to birth before 32 completed weeks of pregnancy. At that stage, the brain is undergoing rapid growth and structural organization. Neural connections are multiplying, the cerebral cortex is becoming more complex, and systems involved in sensory processing, language, attention and social interaction are still developing. When birth occurs during this period, those processes continue in an environment that differs dramatically from the womb. Medical interventions may be lifesaving, but intensive care can also expose infants to fluctuations in oxygen, inflammation, infection, nutritional challenges and other stresses that may influence later development.

Autism is a neurodevelopmental condition associated with differences in social communication, sensory processing, restricted or repetitive behaviors and patterns of attention. It is not caused by a single biological pathway or one environmental exposure. Instead, researchers understand autism as arising from an interaction among many genetic and developmental factors. Premature birth is therefore not considered a direct or inevitable cause of autism. Rather, it may contribute to a more complicated developmental landscape in which vulnerabilities already present in a child’s biology interact with events surrounding pregnancy, birth and early medical care.

The significance of a study focused on children born very preterm lies in its ability to separate broad developmental effects from autism-specific characteristics. Children who arrive extremely early may experience motor, language, cognitive or sensory difficulties for reasons that do not necessarily indicate autism. Conversely, autism-related features may be overlooked when clinicians attribute every developmental difference to prematurity. A carefully designed cohort study can help researchers examine which early characteristics are most informative, how they evolve over time and whether combinations of medical and behavioral factors provide stronger clues than any single sign.

Following children until five years of age is particularly important. By this stage, many children are expected to use increasingly complex language, engage in reciprocal play, adapt their behavior across settings and demonstrate growing independence. These milestones do not develop at exactly the same pace in every child, but the preschool years offer a valuable window for observing persistent patterns. Researchers can assess whether early differences in communication, attention, sensory responses, motor development or emotional regulation remain stable, diminish, or become more clearly defined as the child’s social and cognitive environment becomes more demanding.

Cohort studies are designed to observe a group of participants over time, rather than relying only on a single assessment. This approach can reveal developmental trajectories, which are often more informative than isolated scores. For example, an early delay may represent a temporary consequence of medical complications, while a consistent pattern across several years may signal a need for more targeted evaluation. In children born very preterm, longitudinal research is also essential because developmental pathways can be uneven. A child may show early motor difficulties, later catch up in some areas, and then encounter new challenges when language, peer interaction and executive functions become more complex.

The study’s focus on “risk factors” does not mean that it assigns a deterministic outcome to any child. In medical research, a risk factor is a characteristic statistically associated with a greater probability of a particular outcome. It may be biological, clinical, developmental or environmental, and its influence may be modest. Risk prediction is therefore different from diagnosis. Autism diagnosis requires a comprehensive assessment of behavior and development by qualified professionals, usually drawing on parent reports, clinical observation and standardized tools. No single neonatal complication, developmental delay or screening result can establish that a child is autistic.

The research also arrives at a moment when neonatal medicine has transformed survival for very preterm infants. Advances in respiratory support, infection management, nutritional care and neuroprotective strategies have enabled more babies born early to reach childhood. As survival improves, the scientific focus has expanded beyond mortality and immediate complications to include learning, mental health, social development and quality of life. Studies such as this one may help hospitals design follow-up programs that are more sensitive to the distinct needs of children born very preterm, while helping families obtain developmental support before difficulties become entrenched.

For parents, the most important message is that prematurity should prompt attentive follow-up, not fear or predetermined expectations. Early developmental surveillance can identify strengths as well as areas requiring support. Speech and language services, occupational therapy, behavioral interventions, educational accommodations and family-centered care can all be valuable when matched to an individual child’s needs. The publication by Stone-Heaberlin and colleagues contributes to that broader effort by examining how early risk factors relate to outcomes at age five, a point at which developmental differences can become more visible but meaningful intervention remains possible.

The article, titled “Early autism risk factors: a cohort study of children born very preterm at 5-years,” was published in the Journal of Perinatology and is dated 12 August 2026. Its subject reflects a central challenge in developmental science: translating complex early-life histories into precise, compassionate and useful care. As researchers continue to follow children born very preterm into school age and adolescence, the goal will be not merely to identify risk, but to understand resilience, improve screening and ensure that every child receives support based on their actual development rather than on assumptions linked to the circumstances of their birth.

Subject of Research: Early autism risk factors in children born very preterm, assessed at five years of age.

Article Title: Early autism risk factors: a cohort study of children born very preterm at 5-years.

Article References: Stone-Heaberlin, M., Blackburn, A.D., Tamm, L. et al. “Early autism risk factors: a cohort study of children born very preterm at 5-years.” Journal of Perinatology (2026). https://doi.org/10.1038/s41372-026-02856-x

Image Credits: AI Generated

DOI: 10.1038/s41372-026-02856-x

Keywords: very preterm birth, autism risk factors, neurodevelopment, cohort study, premature infants, early childhood development, autism screening, developmental outcomes

Moderate and late preterm infants (MLPTI) constitute a considerable subset of preterm births, and although often overlooked in comparison to their extremely preterm counterparts, these infants face unique developmental challenges. The study conducted by Lafeber et al. rigorously examines the association between somatic growth parameters—such as weight, length, and head circumference—and neurodevelopmental outcomes, employing a multifaceted assessment framework to capture the complexity of infant development. Importantly, neurodevelopment at two years corrected age is a pivotal endpoint, as it reflects the integration of early brain maturation processes with environmental influences and medical interventions received postnatally.

Diving into the nuances, the researchers utilized a longitudinal cohort design, carefully measuring growth indices at multiple postnatal milestones. This approach allowed for a dynamic understanding of growth velocity rather than static measures. The rationale stems from the biological premise that postnatal catch-up growth, especially of the brain during this sensitive period, may correlate with improved neurodevelopmental progress. Contrarily, growth faltering or suboptimal somatic increases might signal underlying neurobiological adversity or insufficient postnatal support.

Neurodevelopment was gauged using standardized and validated instruments, including cognitive, language, and motor scales calibrated to the corrected age to accommodate for prematurity. This method ensures that assessments accurately reflect developmental progress relative to term-born peers. The inclusion of diverse neurocognitive domains underscores the multifactorial nature of infant brain development and facilitates identification of specific areas susceptible to growth-related influences.

One of the pivotal findings from this extensive cohort study is the positive correlation between optimal growth, particularly in head circumference, and favorable neurodevelopmental outcomes. Head circumference is widely recognized as a proxy for brain volume and maturation, thus its growth trajectory serves as a sensitive biomarker for neurological health. Enhanced head growth was found to be independently associated with superior cognitive and motor performance, suggesting that interventions targeting nutrition and health optimization during the early postnatal period might significantly impact neurodevelopment.

Conversely, infants exhibiting restricted growth or suboptimal increases in body size displayed heightened risks for delays in language acquisition and motor skills, highlighting the intricate interplay between physical growth and brain function. These results emphasize the critical need for vigilant growth monitoring and proactive management in MLPTI, who, despite being premature, are often discharged from neonatal care with fewer concerns compared to extremely preterm infants.

The study also delves into the potential mechanisms underlying these associations. Nutritional status emerges as a key determinant; macro- and micronutrient deficits during critical periods can impair neurogenesis, synaptogenesis, and myelination, thus stunting cognitive and psychomotor development. Furthermore, systemic inflammation, often co-existing with growth faltering, may exacerbate neuronal injury, compounding delays. The researchers advocate for integrative strategies combining optimized nutrition, infection control, and supportive caregiving to promote holistic development.

Moreover, this research expands the dialogue around early childhood interventions by underscoring the value of tailored growth promotion strategies in the outpatient setting. Traditionally, focus has been heavily weighted toward immediate neonatal intensive care unit (NICU) management, but the findings suggest that continued surveillance and support through infancy and toddlerhood are paramount for MLPTI populations. This paradigm shift challenges pediatricians and caregivers alike to reevaluate post-discharge protocols to encompass growth and developmental screenings crucial for timely therapeutic engagement.

Importantly, the authors contextualize their findings within the broader epidemiological landscape, noting the prevalence of MLPTI births globally and the significant public health impact of even modest neurodevelopmental impairments on educational achievement and quality of life. They highlight that subtle delays during early childhood often translate into challenges in school readiness and cognitive performance, compounding socioeconomic disparities if unaddressed. Consequently, advancing understanding in this domain holds promise for reducing long-term disability and fostering equitable health outcomes.

The robustness of the study is further exemplified by its multidisciplinary methodology, integrating pediatric endocrinology, neuropsychology, and developmental pediatrics to holistically interpret growth and neurological data. Advanced statistical modeling controlled for confounding variables such as socioeconomic status, maternal health, and neonatal morbidities, ensuring that observed associations are credible and reflective of true biological phenomena rather than extraneous influences.

While the research marks a significant stride in the field, it acknowledges limitations including the observational design, which precludes definitive causal inferences, and the need for longer-term follow-ups extending into school-age years to fully capture the trajectory of developmental outcomes. Additionally, heterogeneity within the MLPTI group, such as varying levels of medical complications and genetic predispositions, suggest that personalized medicine approaches will be critical in future clinical applications.

Looking forward, this study opens avenues for interventional research exploring whether targeted nutritional supplementation, enhanced parental education, and early therapeutic services can modify growth patterns and, consequentially, neurodevelopmental trajectories. It sets the stage for clinical trials and public health initiatives aimed at refining care pathways for MLPTI, a group whose developmental potential has historically been underestimated.

In summary, the intricate link between growth and neurodevelopmental outcomes underscored in this work crystallizes the importance of comprehensive, sustained clinical attention to moderate and late preterm infants. Far from being simply “almost term,” these infants carry distinct vulnerabilities requiring nuanced strategies to optimize their long-term health and cognitive capacities. As the scientific and medical communities deepen their focus on this population, the promise of healthier developmental trajectories—and by extension, brighter futures—becomes increasingly attainable.

This seminal investigation by Lafeber and colleagues represents a critical contribution to pediatric research, enriching our understanding of how early biological and environmental factors intertwine to shape neurocognitive destinies. The evidence invites a paradigm shift in neonatal and early childhood care practices, advocating for proactive, growth-centered approaches that may transform outcomes for thousands of children worldwide.

By illuminating the powerful association between physical growth and brain development in MLPTI, this research not only informs clinical practice but also resonates with broader societal imperatives to nurture child health from the earliest stages. The findings fortify the argument for investments in early life health monitoring and intervention, strategies that promise to yield dividends across the lifespan and generations.

As the research community continues to unravel the complexities of preterm infant development, studies like this will no doubt catalyze innovations in therapeutic techniques and care models. They serve as a clarion call to prioritize this often-overlooked group of infants, ensuring that their growth and developmental potential are fully supported within healthcare systems and beyond.

Subject of Research: Growth and neurodevelopmental outcomes in moderate and late preterm infants

Article Title: The association between growth and neurodevelopment at 2 years in moderate and late preterms

Article References:
Lafeber, A.H., Bosch, M., Aarnoudse-Moens, C.S.H. et al. The association between growth and neurodevelopment at 2 years in moderate and late preterms. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04581-1

Image Credits: AI Generated

DOI: 25 November 2025